Showing results (681-690 of 9,402) with videos related to

Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|April 18, 2019
Liver Microphysiological Systems for Predicting and Evaluating Drug EffectsAlexandre J S Ribeiro, Xinning Yang, Vikram Patel, et al.
Clinical Pharmacology and Therapeutics|April 20, 2019
Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 DiabetesSophie Gravel, Jean-Louis Chiasson, Fleur Gaudette, et al.
Clinical Pharmacology and Therapeutics|April 21, 2019
A Realistic Review of the Drug-Injury Relief System in Taiwan: Challenges, Lessons, and AchievementsWen-Wen Chen, Mei-Yi Chien, Wan-Lun Wu, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Clinical Pharmacology and Therapeutics|May 10, 2019
A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical TrialsShamir N Kalaria, Hao Zhu, Tiffany R Farchione, et al.
Clinical Pharmacology and Therapeutics|March 31, 2022
Effect of a Ketohexokinase Inhibitor (PF-06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe DrugDavid A Tess, Emi Kimoto, Amanda King-Ahmad, et al.
Clinical Pharmacology and Therapeutics|March 10, 2022
Longitudinal Model-Based Meta-Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With AsthmaShuying Yang, Monica Simeoni, Misba Beerahee
Clinical Pharmacology and Therapeutics|October 1, 1986
Renal safety of two analgesics used over the counter: ibuprofen and aspirinS L Bonney, R S Northington, D A Hedrich, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
The hemodynamic effects of aminophylline and salbutamol alone and in combinationC D Burgess, J Crane, A N Graham, et al.
Clinical Pharmacology and Therapeutics|March 8, 2022
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE StudyMichael Boettcher, Hans-Dirk Düngen, Frank Donath, et al.
Pageof 941